Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.11 CAD | +1.46% | +2.24% | +23.33% |
10:13am | Manulife Opens Macau Office | MT |
Jun. 05 | Manulife Brief: Announcing Results of Conversion Privilege of Non-cumulative Rate Reset Class 1 Shares Series 15 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- With a P/E ratio at 11.08 for the current year and 9.13 for next year, earnings multiples are highly attractive compared with competitors.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.94 for the current period. Therefore, the company is undervalued.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+23.33% | 46.96B | B+ | ||
+8.00% | 76.45B | B- | ||
+7.15% | 50.23B | B | ||
+6.26% | 49.97B | B+ | ||
+13.17% | 42.14B | B+ | ||
+22.27% | 39.33B | B | ||
-0.95% | 28.68B | B | ||
-7.68% | 27.44B | B- | ||
+27.21% | 26.37B | A | ||
-19.91% | 25.14B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MFC Stock
- Ratings Manulife Financial Corporation